Cite
MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603
MLA
John M. Kirkwood, et al. “MicroRNA Expression Profiling Predicts Clinical Outcome of Carboplatin/Paclitaxel-Based Therapy in Metastatic Melanoma Treated on the ECOG-ACRIN Trial E2603.” Clinical Epigenetics, vol. 7, June 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bc622d0c4a2052f9b5840b92234e90d0&authtype=sso&custid=ns315887.
APA
John M. Kirkwood, Panayiotis V. Benos, Marjorie Romkes, Hussein Tawbi, Shama Buch, Katherine L. Nathanson, Keith T. Flaherty, Liza C. Villaruz, Melissa Wilson, Tomoko Nukui, Sandra J. Lee, & Grace T. Huang. (2015). MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603. Clinical Epigenetics, 7.
Chicago
John M. Kirkwood, Panayiotis V. Benos, Marjorie Romkes, Hussein Tawbi, Shama Buch, Katherine L. Nathanson, Keith T. Flaherty, et al. 2015. “MicroRNA Expression Profiling Predicts Clinical Outcome of Carboplatin/Paclitaxel-Based Therapy in Metastatic Melanoma Treated on the ECOG-ACRIN Trial E2603.” Clinical Epigenetics 7 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bc622d0c4a2052f9b5840b92234e90d0&authtype=sso&custid=ns315887.